From: Comparative genomics of Toll-like receptor signalling in five species
Gene | Human | Mouse | Cattle | Relevant function | Mouse | Mouse | Sheep | Cattle |
---|---|---|---|---|---|---|---|---|
 | Chr: Mb | Chr: Mb | Chr: Mb |  | Y.e. | T.c. | H.c. | T.a. |
GPI | 19: 39.5 | 7: 35.0 | 18: 44.5 | humoral immune response | Â | n.a. | n.a. | n.a. |
HAMP | 19: 40.5 | 7: 31.7 | 18: 45.4 | antimicrobial activity of HAMP derived peptides | Â | Â | n.a. | n.a. |
CD22 | 19: 40.5 | 7: 31.7 | 18: 45.5 | inhibition of B cell receptor signalling | Â | 2.24*e | n.a. | n.a. |
TYROBP | 19: 41.1 | 7: 31.2 | 18: 46.0 | activation of NK cells | Â | 2.11**e | n.a. | Â |
FUT1 | 19: 53.9 | 7: 52.9 | 18: 55.2 | creation of an adhesion site | Â | Â | n.a. | n.a. |
FCGRT | 19: 54.7 | 7: 52.3 | 18: 55.9 | IgG fragment receptor | 0.73**b | Â | n.a. | n.a. |
IRF3 | 19: 54.9 | 7: 52.3 | 18: 56.0 | activation of IFN-β |  | 1.22*d |  | n.a. |
PRMT1 | 19: 54.9 | 7: 52.2 | 18: 56.0 | inhibition of viral helicase | Â | Â | n.a. | n.a. |
CCR4 | 3: 33.0 | 9: 114.4 | 22: 7.3 | chemokine receptor | i.s. | Â | n.a. | n.a. |
MYD88 | 3: 38.2 | 9: 119.2 | 22: 11.7 | mediation of signal after TLR-ligand binding | Â | 1.39*d | Â | Â |
CX3CR1 | 3: 39.3 | 9: 120.0 | 22: 12.8 | chemokine receptor | 0.54**a | 2.09*c | n.a. | Â |
CCR8 | 3: 39.3 | 9: 120.0 | 22: 12.8 | chemokine receptor | i.s. | Â | n.a. | n.a. |
VIPR1 | 3: 42.5 | 9: 121.6 | 22: 15.0 | binding of anti-inflammatory peptide | i.s | Â | n.a. | n.a. |
CCBP2 | 3: 42.8 | 9: 121.8 | 22: 15.3 | chemokine receptor | i.s. | 1.53*e | n.a. | n.a. |
TLR10 | 4: 38.5 | n.o. | 6: 60.3 | binding of unknown ligand | n.o. | n.o. | 2.40* | 1.71* |
TLR1 | 4: 38.5 | 5: 65.3 | 6: 60.4 | binding of ligands derived from gram-positive bacteria | Â | 1.37*c | Â | Â |
TLR6 | 4: 38.5 | 5: 65.3 | 6: 60.4 | binding of ligands derived from gram-positive bacteria | Â | 0.61*d | Â | Â |
RFC1 | 4: 39.0 | 5: 65.7 | 6: 60.8 | replication factor C (activator 1) 1, | defence response | Â | 0.50*b | n.a. |